20/20 BioLabs meets potential partners in East Asia
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
20/20 Biolabs Inc (AIDX)
The 20/20 Biolabs share price today is 0.43, view NASDAQ AIDX stock exchange data. Track the latest 20/20 Biolabs share price with real-time updates on AIDX stock performance including market cap, day range, 52-week range and dividend yield. Access AIDX charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.42
0.44
52 wk Range
0.40
50.00
AIDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.420.44
52 wk Range
0.4050.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AIDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
5.00
Upside
+1,062.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
20/20 Biolabs stock surges on Ebola testing plans- Investing.com
- 20/20 BioLabs meets potential partners in East Asia
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.00
(+1,062.79% Upside)
Earnings
Latest Release
20-05-2026
EPS / Forecast
-0.28 / --
Revenue / Forecast
353.38K / --
Compare AIDX to Peers and Sector
Metrics to compare | AIDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAIDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −1.5x | −0.3x | |
PEG Ratio | −0.06 | 0.04 | 0.00 | |
Price/Book | 1.8x | 1.4x | 2.6x | |
Price / LTM Sales | 2.5x | 1.1x | 3.0x | |
Upside (Analyst Target) | - | 70.0% | 56.7% | |
Fair Value Upside | Unlock | 19.7% | 9.4% | Unlock |
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the 20/20 Biolabs (AIDX) Share Price Today?
The 20/20 Biolabs share price today is 0.43.
What is the current 20/20 Biolabs (AIDX) share price and day range?
As of 01-08-2026, the 20/20 Biolabs share price is 0.43, with a previous close of 0.40. The share price has ranged from 0.42 to 0.44 today, while the 52-week range spans from 0.40 to 50.00.
What Is the 20/20 Biolabs Market Cap?
As of today, 20/20 Biolabs market cap is 4.26M.
What Is the 20/20 Biolabs (AIDX) Share Price Target?
The average 12-month share price target for 20/20 Biolabs is 5.00, with a high estimate of 5 and a low estimate of 5. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +1,062.79% Upside potential.
What Is 20/20 Biolabs's Earnings Per Share (TTM)?
The 20/20 Biolabs EPS (TTM) is -0.90.
When Is the Next 20/20 Biolabs Earnings Date?
20/20 Biolabs will release its next earnings report on 02-09-2026.
From a Technical Analysis Perspective, Is AIDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does 20/20 Biolabs Trade On?
20/20 Biolabs is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for 20/20 Biolabs?
The stock symbol for 20/20 Biolabs is "AIDX."
How Many Times Has 20/20 Biolabs Stock Split?
20/20 Biolabs has split 0 times.
How Many Employees Does 20/20 Biolabs Have?
20/20 Biolabs has 9 employees.
What Is the AIDX Premarket Price?
AIDX's last pre-market stock price is 0.44. The pre-market share volume is 8,010.00, and the stock has changed by 0.04, or 10.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.